US2015071956A1PendingUtilityA1

NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)

Assignee: FORSGREN ARNEPriority: Jan 17, 2006Filed: Nov 20, 2013Published: Mar 12, 2015
Est. expiryJan 17, 2026(expired)· nominal 20-yr term from priority
A61P 31/04A61P 27/16A61P 29/00A61P 31/16C07K 14/285A61P 11/02A61K 39/102A61P 11/08C07K 16/12A61P 11/00A61K 39/012A61P 31/00A61K 39/00
61
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a surface exposed protein (protein E, pE), a virnlence factor, which can be detected in Haemophilus influenzae , having an amino acid sequence as described in SEQ ID NO 1, an immunogenic fragment of said surface exposed protein, and a recombinant immunogenic protein (pE (A)) or truncated variants thereof based on said surface exposed protein. Nucleic acid sequences, vaccines, plasmids and phages, non human hosts, recombinant nucleic acid sequences, fusion proteins and fusion products are also described. A method of producing the said protein or truncated fragments thereof recombinantly is also disclosed.

Claims

exact text as granted — not AI-modified
1 . A vaccine composition comprising a surface exposed protein, which can be detected in  Haemophilus influenzae , having an amino acid sequence as described in Sequence ID No. 1, or a fragment thereof, wherein the fragment comprises an amino acid sequence having at least 15 contiguous amino acids from the amino acid sequence of SEQ ID NO:1 which fragment (if necessary when coupled to a carrier) is capable of raising an immune response which recognises the polypeptide of SEQ ID NO:1. 
     
     
         2 - 85 . (canceled)

Join the waitlist — get patent alerts

Track US2015071956A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.